Hostname: page-component-7b7567c8c-2n9c9 Total loading time: 0 Render date: 2026-11-16T11:11:14.862Z Has data issue: false hasContentIssue false

Inulin/oligofructose and anticancer therapy

Published online by Cambridge University Press:  09 March 2007

H. S. Taper*
Affiliation:
Unité de Pharmacocinétique, Métabolisme, Nutrition et Toxicologie, Université Catholique de Louvain, PMNT 73.69, Avenue Em. Mounier, 73, B – 1200 Bruxelles, Belgium
M. B. Roberfroid
Affiliation:
Unité de Pharmacocinétique, Métabolisme, Nutrition et Toxicologie, Université Catholique de Louvain, PMNT 73.69, Avenue Em. Mounier, 73, B – 1200 Bruxelles, Belgium
*
*Corresponding author: Dr H. S. Taper, Tel.: +32 2 764 73 69, fax: +32 2 764 73 59, email ferdinand@pmnt.ucl.ac.be
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the 'Save PDF' action button.

The results of our investigations indicate that dietary treatment with inulin or oligofructose incorporated in the basal diet for experimental animals: (i) reduced the incidence of mammary tumors induced in Sprague-Dawley rats by methylnitrosourea; (ii) inhibited the growth of transplantable malignant tumors in mice; and (iii) decreased the incidence of lung metastases of a malignant tumor implanted intramuscularily in mice. Moreover, besides such cancer risk reduction effects, the dietary treatment with inulin or oligofructose significantly potentiated the effects of subtherapeutic doses of six different cytotoxic drugs commonly utilized in human cancer treatment. If confirmed, such dietary treatment with inulin or oligofructose potentiating cancer therapy might become an interesting approach to complement classical protocols of human cancer treatment without any additional risk for the patients.

Information

Type
Research Article
Copyright
Copyright © The Nutrition Society 2002